These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7593449)

  • 41. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
    Puurunen J; Piltonen T; Puukka K; Ruokonen A; Savolainen MJ; Bloigu R; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4798-807. PubMed ID: 24152688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
    Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD; Allan G
    N Engl J Med; 1999 Apr; 340(17):1314-20. PubMed ID: 10219066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial.
    Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B
    J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion.
    Lanzone A; Fulghesu AM; Cucinelli F; Ciampelli M; Caruso A; Mancuso S
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3501-6. PubMed ID: 8530590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors.
    Vidal-Puig A; Muñoz-Torres M; Jodar-Gimeno E; García-Calvente C; Lardelli P; Ruiz-Requena ME; Escobar-Jiménez F
    Clin Investig; 1994 Nov; 72(11):853-7. PubMed ID: 7894211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial.
    Heshmati J; Moini A; Sepidarkish M; Morvaridzadeh M; Salehi M; Palmowski A; Mojtahedi MF; Shidfar F
    Phytomedicine; 2021 Jan; 80():153395. PubMed ID: 33137599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of nutrition and insulin in the regulation of sex hormone binding globulin.
    Franks S; Kiddy DS; Hamilton-Fairley D; Bush A; Sharp PS; Reed MJ
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):835-8. PubMed ID: 1954173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.
    Ciotta L; De Leo V; Galvani F; La Marca A; Cianci A
    Hum Reprod; 1999 Dec; 14(12):2951-8. PubMed ID: 10601077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome.
    Vidal-Puig A; Muñoz-Torres M; Garcia-Calvente C; Jodar-Gimeno E; Lardelli P; Ruiz-Requena ME; Escobar-Jiménez F
    J Endocrinol Invest; 1994 Sep; 17(8):647-52. PubMed ID: 7868804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin regulation of human ovarian androgens.
    Nestler JE
    Hum Reprod; 1997 Oct; 12 Suppl 1():53-62. PubMed ID: 9403321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women.
    Beer NA; Jakubowicz DJ; Beer RM; Nestler JE
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1077-81. PubMed ID: 7962276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women.
    Nestler JE; Singh R; Matt DW; Clore JN; Blackard WG
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1243-6. PubMed ID: 2220936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of nifedipine and nitrendipine on insulin secretion in obese patients.
    Valensi P; Uzzan B; Attali JR; Perret G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S91-3. PubMed ID: 1723467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries.
    Kim MH; Rosenfield RL; Hosseinian AH; Schneir HG
    Am J Obstet Gynecol; 1979 Jun; 134(4):445-52. PubMed ID: 572140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome.
    Nestler JE; Clore JN; Blackard WG
    Am J Obstet Gynecol; 1989 Nov; 161(5):1095-7. PubMed ID: 2686438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.